High materiality7/10
Immunome price target raised to $35 from $31 at Wedbush
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wedbush increases IMNM target to $35; current price $26.27; priceChangeSinceSignal 6.55; upside potential remains.
- Target above current price; potential upside.
Key facts
- 01
Target: $35
- 02
Posted price: $26.27
- 03
Analyst firm: Wedbush
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.